RecruitingPHASE1, PHASE2NCT02275286
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Studying Pleomorphic liposarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Grupo Espanol de Investigacion en Sarcomas
- Principal Investigator
- Javier Martín-Broto, MDJiménez Díaz Foundation University Hospital
- Intervention
- Trabectedin(drug)
- Enrollment
- 199 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2028
Study locations (17)
- Institut Bergonié, Bordeaux, France
- Centre Léon Berard, Lyon, France
- Istituto Clinico Humanitas, Rozzano, Milan, Italy
- Centro di Referimento Ocologico, Aviano, Italy
- Istituto Ortopedico Rizzoli, Bologna, Italy
- Candiolo Cancer Institute, Candiolo, Italy
- Istituto Nazionale dei Tumori, Milan, Italy
- Hospital Miguel Servet, Zaragoza, Aragon, Spain
- Hospital Sant Pau, Barcelona, Catalonia, Spain
- Hospital Son Espases, Palma de Mallorca, Mallorca, Spain
- Hospital Universitario Canarias, San Cristóbal de La Laguna, Tenerife, Spain
- Hospital Vall d'Hebrón, Barcelona, Spain
- Hospital Puerta de Hierro, Madrid, Spain
- Hospital Universitario Gregorio Marañón, Madrid, Spain
- Hospital Uniersitario La Paz, Madrid, Spain
- +2 more locations on ClinicalTrials.gov
Collaborators
Centre Leon Berard · Italian Sarcoma Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02275286 on ClinicalTrials.govOther trials for Pleomorphic liposarcoma
Additional recruiting or active studies for the same condition.